Healthcare Services

An Important Factor Driving the Myopia and Presbyopia Treatment Market Is the Rising Incidence Of Vision Impairment Drives The Growth Of Myopia And Presbyopia Treatment Market

April 2, 2026April 2, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Myopia and Presbyopia Treatment Market From 2026 To 2030?

The myopia and presbyopia treatment market size has shown significant growth over the past few years. It is anticipated to expand from $22.63 billion in 2025 to $24.56 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.6%. The historical surge in this market can be linked to an expanding aging population, the widespread adoption of corrective lenses, the increase in screen-induced myopia, early advancements in refractive surgery, and limited awareness of preventive eye care.

The market size for myopia and presbyopia treatment is anticipated to show considerable growth over the upcoming years. It is projected to expand to $33.57 billion by 2030, progressing at a compound annual growth rate (CAGR) of 8.1%. The expansion during this forecast period stems from factors such as increasing demand for sophisticated surgical solutions, a rise in the adoption of presbyopia-correcting lenses, a growing utilization of pharmacological treatments, innovations in eye care diagnostic technologies, and the extension of preventive screening programs. Key trends expected over the forecast period encompass a rising embrace of multifocal and advanced contact lenses, an increasing call for laser and refractive surgical procedures, a developing preference for orthokeratology (ortho-k) in myopia control, enhanced use of pharmacological eye drops for presbyopia, and the broadening of early vision screening and preventive care initiatives.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7892&type=smp

What Major Drivers Are Influencing Demand In The Myopia and Presbyopia Treatment Market?

The increasing occurrence of vision impairment is projected to boost the growth of the myopia and presbyopia treatment market. Vision impairment describes a condition in which an individual’s ability to see and interpret visual information is significantly reduced, leading to difficulties in perceiving and understanding the surrounding environment. The expanding incidence of vision impairment can stimulate the development of myopia and presbyopia treatments, fostering increased awareness, innovation, investments, improved access to care, and ultimately better outcomes for individuals seeking solutions for their vision issues. For instance, in August 2023, global estimates from the World Health Organization (WHO) indicated that 2.2 billion people have near or distance vision impairment, including 1 billion cases that are preventable or untreated. Refractive errors and cataracts remain the leading global causes of vision loss, yet only 36% of individuals with refractive-error–related distance impairment and just 17% of those with cataract-related impairment have received appropriate care. Therefore, the rising incidence of vision impairment is driving the expansion of the myopia and presbyopia treatment market.

Which Segments Are Included In The Analysis Of The Myopia and Presbyopia Treatment Market?

The myopia and presbyopia treatment market covered in this report is segmented –

1) By Type: Myopia, Presbyopia

2) By Age Group: Children And Young Adults, Adults, Geriatrics

3) By End-Use: Hospitals, Eye Care Clinics Or Ophthalmic Centers

Subsegments:

1) By Myopia: Pharmacological Treatments, Orthokeratology Lenses, Refractive Surgery, Spectacles And Contact Lenses

2) By Presbyopia: Multifocal Lenses, Monovision Contact Lenses, Corneal Inlays, Presbyopia-Correcting Surgery

Which Market Trends Are Creating New Opportunities In The Myopia and Presbyopia Treatment Market?

Leading companies in the myopia and presbyopia treatment market are developing innovative products, such as myopia combating sun spectacle lenses, to serve larger customer bases, achieve more sales, and increase revenue. Myopia-combating sun spectacle lenses refer to eyeglass lenses specifically designed to help slow the progression of myopia, also known as near-sightedness, when worn outdoors or in bright sunlight. For instance, in May 2023, HOYA, a Thailand-based optical technology company, introduced MiYOSMART sun spectacle lenses to address myopia in children. MiYOSMART’s distinctiveness lies in its inventive approach to decelerating myopia progression in children while simultaneously offering protection from intense sunlight. This is achieved through two specialized lens options: the photochromic spectacle lenses, MiYOSMART Chameleon, and the polarized spectacle lenses, MiYOSMART Sunbird, both incorporating DIMS Technology (Defocus Incorporated Multiple Segments). Developed in collaboration with the Hong Kong Polytechnic University, DIMS Technology operates on the principle of generating simultaneous defocus during both distance and near viewing. This involves one plane on the retina due to the single vision zone(s) of the lens, while another plane creates myopic defocus through the use of +3.50D defocus lenslets.

Which Key Industry Participants Are Active In The Myopia and Presbyopia Treatment Market?

Major companies operating in the myopia and presbyopia treatment market are ALCON Inc., Bausch & Lomb Incorporated, Carl Zeiss AG, Essilor Ltd., Johnson & Johnson Vision Inc., Nidek Corporation, Topcon Corporation, Zimmer Ophthalmic Systems AG, AbbVie Inc., Orasis Pharmaceuticals Ltd., The Cooper Companies Inc., Staar Surgical Co., Eyenovia Inc., Allergan PLC, Hoya Corporation, Menicon Co. Ltd., CooperVision Inc., Visioneering Technologies Inc., AcuFocus Inc., Ocular Therapeutix Inc., SightGlass Vision Inc., Presbia PLC, LensGen Inc., RxSight Inc., Perfect Lens LLC

Read the full myopia and presbyopia treatment market report here:

https://www.thebusinessresearchcompany.com/report/myopia-and-presbyopia-treatment-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Myopia and Presbyopia Treatment Market?

North America was the largest region in the myopia and presbyopia treatment market share in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the myopia and presbyopia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Myopia and Presbyopia Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=7892&type=smp

Browse Through More Reports Similar to the Global Myopia and Presbyopia Treatment Market 2026, By The Business Research Company

Surgical Stapling Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/surgical-stapling-devices-global-market-report

Powered Surgical Instruments Global Market Report

https://www.thebusinessresearchcompany.com/report/powered-surgical-instruments-global-market-report

Urology Surgical Instruments Global Market Report

https://www.thebusinessresearchcompany.com/report/urology-surgical-instruments-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795